ARVINAS, INC.
Ticker: 1655759
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 15.60-62.8% | 41.90+87.1% | 22.40-88.1% | 188.80+84.4% | 102.40+33.9% | 76.50+202.4% | 25.30-26.9% | 34.60 |
| Total Income | 15.60-62.8% | 41.90+87.1% | 22.40-88.1% | 188.80+84.4% | 102.40+33.9% | 76.50+202.4% | 25.30-26.9% | 34.60 |
| EXPENSES | ||||||||
| Expenditure | 79.40-7.4% | 85.70-8.7% | 93.90-20.0% | 117.40-27.8% | 162.70+30.2% | 125.00+15.1% | 108.60+0.1% | 108.50 |
| Tax | 0.10-66.7% | 0.30+200.0% | -0.30-250.0% | 0.20-66.7% | 0.60+200.0% | 0.20+100.0% | 0.10 | 0.00 |
| PROFIT | ||||||||
| PBT | -57.50-65.2% | -34.80+43.4% | -61.50-174.0% | 83.10+271.0% | -48.60-38.9% | -35.00+49.5% | -69.30-8.5% | -63.90 |
| Net Profit | -57.60-64.1% | -35.10+42.6% | -61.20-173.8% | 82.90+268.5% | -49.20-39.8% | -35.20+49.3% | -69.40-8.4% | -64.00 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00%-137.82pp | 37.82%+96.70pp | -58.89%+4.51pp | -63.40%+36.60pp | -100.00% | -100.00% |
| NPM % | -100.00%-16.23pp | -83.77%+16.23pp | -100.00%-143.91pp | 43.91%+91.96pp | -48.05%-2.03pp | -46.01%+53.99pp | -100.00% | -100.00% |
| EPS | -0.90-87.5% | -0.48+42.9% | -0.84-173.7% | 1.14+267.6% | -0.68-38.8% | -0.49+49.5% | -0.97+17.8% | -1.18 |
Corporate Events
Board MeetingARVN
20263Jul
Board Meeting
Chief Medical Officer Transition — Dr. Noah Berkowitz to dep…
SEC Filing ↗ Board MeetingARVN
202624Jun
Board Meeting
Annual Meeting of Stockholders to elect two Class II directo…
SEC Filing ↗